The global prefilled syringes market size is estimated to grow from USD 3.02 billion in 2024 to USD 4.97 billion by 2035, representing a CAGR of 4.6% during the forecast period till 2035.
With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune disorders, cardiovascular disorders and oncological disorders, are witnessing an upward trend. Various conditions require regular and long-term medications, driving a demand for reliable drug delivery systems. Further, non-adherence to prescribed medication regimen is one of the major factors that not only causes negative implications on the patient’s health, but also adds to the overall pharmaceutical industry’s burden. According to an article published by Contract Pharma in April 2022, non-adherence to prescribed medicines is estimated to cost more than USD 250 billion annually to the drug developers.
As a result, drug delivery devices have undergone significant advancements in the recent years, providing various options to administer a myriad of drugs (catering to different indications) with accuracy and ease. Among the various innovations, prefilled syringes have gained prominence in the healthcare domain as they offer various advantages, including simplified drug administration process (as there is no need for manual filling of drugs), decreased dosing errors (as the syringe is preloaded with precise medication), reduced risk of contamination (as the prefilled syringes are sealed) and enhanced patient adherence (as they can be readily administered in home settings).
Notably, the prefilled syringes domain has witnessed some innovations, that have been mentioned below:
Needle Safety Features: Needle safety mechanisms such as shielded needles or retractable needles have been incorporated to prevent needle stick injuries and improve safety of the devices.
Integration of Autoinjectors: Autoinjectors have been incorporated with prefilled syringes to offer user friendly and automated drug administration.
Dual Chamber Prefilled Syringes: These syringes allow mixing to two different drugs, such as lyophilized drugs and diluents, just prior to their administration
Flush Syringes: These syringes are designed for flushing vascular access devices, such as catheters and intravenous lines
Prefilled Syringes Market Landscape
The current market landscape features the presence of close to 125 prefilled syringes that are currently available / under development for the delivery of different types of medications. The prefilled syringes market is highly fragmented, featuring the presence of established companies, as well as emerging start-ups. Majority of the companies engaged in this domain are headquartered in Asia-Pacific; of these, over 40% are based India.
Notably, players engaged in this domain are shifting their focus towards the development of plastic prefilled syringes; this can be attributed to the various advantages offered by these syringes, including breakage resistance, light-weight, economical manufacturing and decreased risk of contamination. Further, over 5% of the syringes are available in both glass as well as plastic barrel format.
Most of the prefilled syringes are being developed with luer needle system; these syringes have threaded rims provides a unique locking system, thereby, preventing the needle from being pulled off by the syringe body inadvertently. Further, prefilled syringes are developed in different volume formats, considering the preferences and needs of the customers.
Innovative Pairing: Prefilled Syringe combination products shaping healthcare
During our research, we identified over 120 drugs that have received approval to be used in combination with prefilled syringes, during the period 2013-2023 (till October) and over 50 drugs that are currently being developed in combination with prefilled syringes.
Majority of the drugs being evaluated in late stages of development (phase I/II or phase III) are targeting autoimmune disorders. It is worth mentioning that subcutaneous route is the most preferred route for drug administration by these combination products due to reduced pain and discomfort, convenient self-administration and stable drug absorption.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/prefilled-syringes-market/284.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek